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HAGOCYTOSIS OF IgG-coated cells and microorgan-
isms, an important component of host defense, is mediated by receptors for the Fc portion of IgG (Fc␥ receptors) expressed on monocytes/macrophages and neutrophils. [1] [2] [3] [4] The 3 classes of Fc␥ receptors (Fc␥RI, Fc␥RII, and Fc␥RIII) differ by size, structure, ligand binding specificity, and cellular distribution. [1] [2] [3] The importance of Fc␥ receptors in host defense is highlighted by disorders such as systemic lupus erythematosus and chronic renal and liver failure, in which enhanced susceptibility to infection is associated with a downregulation of Fc␥ receptors. [5] [6] [7] Likewise, when there is a deficiency in the number and/or function of mononuclear and/or polymononuclear phagocytes, such as occurs in association with chemotherapy and prolonged administration of corticosteroids, the adaptive immune system cannot effectively use IgG opsonization as a strategy to aid in host defense. [8] [9] [10] [11] Based on these concepts, we hypothesized that in vivo clearance of IgG-coated cells might be enhanced by inducing Fc␥ receptor expression in normally nonphagocytic cells in the liver, an organ that normally plays a major role in the clearance of IgG-coated complexes. [12] [13] [14] To evaluate this hypothesis, we used an adenovirus (Ad) gene transfer vector to express normal human Fc␥RIIA, a Fc␥RII allotype with affinity for IgG2, 2, 15 cDNA in rat liver cells in vitro and in vivo, and evaluated the ability of the modified liver cells to phagocytize opsonized red blood cells. The in vitro data demonstrate that Fc␥RIIA cDNA genetic modification of primary rat hepatocytes enhances the ability of these cells to bind and phagocytize IgG opsonized cells. The in vivo data demonstrate that Fc␥RIIA cDNA transfer to hepatocytes enhances the clearance of IgG opsonized cells by the liver from the circulation.
MATERIALS AND METHODS
Adenovirus vectors.
The replication-deficient recombinant Ad vectors AdCMVFc␥RIIA and AdCMVNull are both E1a Ϫ , partial E1b Ϫ , partial E3 Ϫ vectors based on adenovirus type 5 (Ad5), in which an expression cassette containing a promoter driving the expression of a recombinant gene is inserted at the site of the E1 deletion. 16, 17 AdCMVFc␥RIIA contains an expression cassette of the cytomegalovirus (CMV) early/intermediate promoter/enhancer followed by the human Fc␥RIIA cDNA isoform H/R 131 18 and a SV 40 stop/poly (A) signal. AdCMVNull is identical, except that it lacks the gene in the expression cassette. 19 The Ad vectors were propagated, purified, and stored at Ϫ70°C, as previously described. 16, 17 Titers of viral preparations were determined by plaque assay using 293 cells. 20 51 Cr-SRBC to the Fc␥RIIA cDNA-modified hepatocytes, the hepatocytes were washed 3 times in PBS and then lysed by incubation in 0.5% sodium dodecyl sulphate (SDS) solution (Sigma) for 10 minutes. To evaluate phagocytosis, hepatocytes were incubated with SRBC for 60 minutes, washed 3 times in PBS, incubated for 60 seconds in hypotonic SRBC lysing buffer (31 mmol/L ammonia chloride, 2 mmol/L potassium bicarbonate, 20 µmol/L ethylenediaminetetraacetic acid; all from Sigma) to lyse bound noninternalized SRBC, washed, and then lysed in 0.5% SDS for 10 minutes. To evaluate phagocytosis at different time points, hepatocytes were incubated with SRBC for 10, 30, and 60 minutes. The hepatocyte to SRBC ratio for all incubations was 1:500. The radioactivity of lysates was measured using a gammacounter.
Expression and function of Fc␥RIIA in vivo. To evaluate the expression of Fc␥RIIA cDNA and the function of Fc␥RIIA protein in vivo, female Sprague-Dawley rats (250 to 300 g) were anesthetized by intramuscular injection of ketamine (60 mg/kg) and xylazine (5 mg/kg). Based on the knowledge that greater than 90% of an intravenously administered Ad goes to the liver, 24,25 the Ad vectors (AdCMVFc␥RIIA, AdCMVNull) were administered to the liver via the external jugular vein (10 9 plaque-forming units [pfu] in 100 µL 0.9% NaCl). Naive animals were used as controls.
Northern analysis was used to demonstrate in vivo Fc␥RIIA transcripts in the liver. After 48 hours, animals were killed (pentobarbital overdose intraperitoneally), total RNA was extracted, and expression of Fc␥RIIA mRNA was assessed by Northern analysis. Total RNA was extracted (RNA Extraction Kit; Clontech, Palo Alto, CA) and transferred (10 µg/lane) to nylon membranes after electrophoretic separation through a 1% agarose gel. The membranes were assessed using a human Fc␥RIIA cDNA probe labeled with 32 P-deoxycytidine triphosphate (dCTP; Random Primer Labeling Kit; Stratagene, La Jolla, CA) for 2 hours using standard methods. 26 32 P-labeled human ␥-actin cDNA was used as a positive control. 22 To analyze the expression and distribution of the Fc␥RIIA in the liver, livers were harvested 48 hours after administration of AdFc␥RIIA, AdNull or from uninfected animals. The organs were fixed with 4% paraformaldehyde for 24 hours and then transferred to 70% ethanol before embedding. Immunohistochemical staining for Fc␥RIIA was performed on 5-µm, paraffin-embedded sections using the anti-Fc␥RII antibody IV.3. An isotype (IgG2b) -matched antibody was used as a control. The antibodies were incubated for 16 hours at 4°C and then washed and incubated with biotinylated rabbit antimouse [F(abЈ) 2 ] (Boehringer Mannheim) for 30 minutes, followed by streptavidin-FITC (Boehringer Mannheim) for 30 minutes.
A rabbit anti-FITC alkaline phosphatase-labeled antibody (Boehringer Mannheim) was then incubated for 30 minutes, followed by detection with 4-nitro blue tetrazolium chloride (NBT)-5-bromo-4-chloro-3-indoyl-phosphate (BCIP) substrate (Boehringer Mannheim). The samples were counterstained with nuclear fast red (DIGENE, Beltsville, MD) and analyzed by light microscopy.
To determine if in vivo transfer of the Fc␥RIIA to the liver was associated with enhanced clearance of IgG opsonized RBC from the circulation, rats were anesthetized and Ad vectors were administered as described above. Forty-eight hours later, 51 Cr-labeled rat red blood cells (RRBC) were opsonized with IgG rabbit anti-RRBC antibodies (Accurate). The IgG-coated, 51 Cr-labeled RRBC were administered intravenously via the femoral vein (3.4 ϫ 10 8 RRBC in 500 µL 0.9% NaCl). Nonopsonized 51 Cr-labeled RRBC were used as controls. At 5, 15, 30, 60, 90, and 120 minutes after injection of the 51 Cr-labeled RRBC, blood samples were collected (100 µL) from the external jugular vein and radioactivity of the samples was measured using a gamma counter. Clearance of RBC from the circulation was expressed as a percentage of RBC survival in the peripheral blood. 27 The value obtained at 5 minutes after injection was considered 100%. Animals were killed after 120 minutes by pentobarbital overdose.
To determine the uptake of the IgG-opsonized 51 Cr-labeled RRBC in different organs, rats were infected with Ad vectors, and then opsonized and nonopsonized RRBC were administered as described above. Animals were killed 120 minutes after administration of the RRBC. Liver, lung, and spleen were removed, weighed, and homogenized in 20 mL of H 2 O. Total radioactivity of the organ (dpm) was determined using To further analyze the uptake of IgG coated particles in vivo, fluorescent-labeled IgG-coated microspheres were injected intravenously in rats that had been infected with AdFc␥RIIA or AdNull 48 hours previously. The fluorescent microspheres were prepared by mixing Sulfo-NHS-LC-Biotin (Pierce, Rockford, IL) with human IgG (Sigma) for 10 minutes at 4°C, pH 8.0, followed by the addition of glycine (1 mg/mL) to stop the reaction and dialysis in 10 mmol/L HEPES, 140 mmol/L KCl, pH 7.2, for 2 hours to remove unbound biotin. The biotinylated IgG was then bound to 40 nm Neutr-Avidinlabeled red fluorescent microspheres (Molecular Probes, Eugene, OR). The number of microspheres injected was 6 ϫ 10 12 particles/animal. One hour after the injection of the fluorescent-coated microspheres, the animals were killed and frozen sections of the livers were prepared by immediately freezing the tissue in TBS tissue freezing medium (Electron Microscopy Sciences, Fort Washington, PA). Frozen sections were fixed in 4% paraformaldehyde for 30 minutes and evaluated by fluorescence microscopy.
Statistical analysis. The results are expressed as the mean Ϯ standard error of the mean. Statistical comparisons were made using the unpaired 2-tailed Student's t-test.
RESULTS
AdFc␥RIIA transfer to rat hepatocytes in vitro. To demonstrate the ability of an Ad vector expressing the AdFc␥RIIA cDNA (AdFc␥RIIA) to transfer and express human Fc␥RIIA in vitro in rat hepatocytes, primary rat hepatocyte cultures were infected with AdFc␥RIIA (moi, 10). Quantification of expression of Fc␥RIIA on the cell surface, determined by flow cytometry, demonstrated positive Fc␥RIIA staining in 46% of cells after AdFc␥RIIA infection (Fig 1) . No expression of Fc␥RIIA was demonstrated in noninfected or AdNull-infected primary rat hepatocytes. These results suggest that Ad-mediated Fc␥RIIA cDNA transfer results in expression of the transgene in primary rat hepatocyte tissue cultures.
Function of Fc␥RIIA transferred in vitro to rat hepatocytes. Function of the Fc␥RIIA protein expressed on the primary rat hepatocytes after in vitro Ad-mediated gene transfer was assessed using a phagocytic assay using radiolabeled SRBC. Cells infected with AdFc␥RIIA (moi, 10) showed increased binding of IgG-coated SRBC (Fig 2A; P Ͻ (Fig 2B; P Ͻ .006, for 30 and 60 minutes compared with values for noninfected and AdNull-infected cells). Increased binding and phagocytosis by hepatocytes expressing Fc␥RIIA was observed after 10 minutes of incubation with opsonized erythrocytes with significant increase and plateau after 30 and 60 minutes. Noninfected and AdNull-infected rat hepatocytes showed a minimal amount of nonspecific binding and internalization of both nonopsonized and IgG-opsonized SRBC. These observa- (Fig 3C and  E) , but not in control naive (Fig 3A and D) or AdNull-infected animals (Fig 3B and E) . These observations confirm that in vivo Ad-mediated transfer of Fc␥RIIA results in expression of the Fc␥RIIA transgene in the liver.
AdFc␥RIIA induced enhanced clearance of opsonized RBC in vivo. The function of Fc␥RIIA expressed after intravenous administration of AdFc␥RIIA (10 9 pfu) was assessed by the clearance of radiolabeled IgG-opsonized and nonopsonized RRBC from the peripheral blood of experimental animals. Nonopsonized RRBC were not effectively cleared in noninfected animals or in AdNull and AdFc␥RIIA-infected animals (Fig 4A; P Ͼ . 2, all comparisons, all time points). In contrast, IgG-coated (opsonized) RRBC were rapidly cleared from the blood in the animals receiving AdFc␥RIIA. One hour after administration of RRBC in noninfected animals, 54% Ϯ 3% RRBC remained in the blood compared with 33% Ϯ 4% in AdNull and 9% Ϯ 1% in Fc␥RIIA-infected animals (Fig 4B; P Ͻ .001, comparing values for Fc␥RIIA-infected animals with AdNull and noninfected animals at all time points after intravenous injection of radiolabeled RRBC). Interestingly, infection with AdNull also increased clearance of IgG-coated RRBC compared with noninfected animals, but much less than that observed with AdFc␥RIIA (P Ͻ .01, all comparisons).
To determine the uptake of RRBC in different organs (liver, lung, and spleen), animals were killed 120 minutes after administration of radiolabeled RRBC. No significant difference was observed in uptake of nonopsonized RRBC in noninfected and AdNull and AdFc␥RIIA-infected animals (Fig 5A; P Ͼ .3,  all comparisons) . In contrast, AdFc␥RIIA-infected animals showed significant increase in the liver uptake of IgG-coated RRBC (69% Ϯ 6%) compared with AdNull infected (41% Ϯ 4%) and noninfected animals (27% Ϯ 2%; Fig 5B; P Ͻ .04, AdFc␥RIIA-infected animals with AdNull and noninfected animals). An increased number of IgG-coated fluorescent microspheres was present in the liver sections of the animals infected with Ad Fc␥RIIA (Fig 6C) compared with naive controls (Fig 6A) or animals infected with AdNull (Fig 5B) . The presence of fluorescent microspheres in the control and Ad Null group most likely reflects the uptake by resident liver macrophages. Taken together, these observations provide evidence that Ad-mediated transfer of Fc␥RIIA cDNA leads to the expression of a functional phagocytic receptor in hepatocytes and transforms these normally nonphagocytic cells into cells that are able to internalize opsonized particles and enhance their clearance from the peripheral blood. Fc␥RIIA receptor. Fc␥ receptors are receptors on the surface of phagocytic cells that recognize and bind the Fc portion of the IgG molecule. [1] [2] [3] [4] In humans, there are 3 major Fc␥ receptors: Fc␥RI (CD64), Fc␥RII (CD32), and Fc␥RIII (CD16). They all exhibit a disulfide loop structure in their extracellular domain that is characteristic for all Ig gene superfamily members. Additional heterogeneity of the Fc␥ receptors results in the occurrence of different allelic forms. 28, 29 The Fc␥RIIA allotype is a 40-kD protein with wide cellular distribution and is present on the surface of monocytes, macrophages, granulocytes, platelets, Langerhans' cells, B and T lymphocytes, and 15 and incubation with inhibitors of tyrosine kinase reduced phagocytic function of the transfected cells. 33 In the present study, expression of Fc␥RIIA was observed in liver parenchymal cells. Furthermore, increased clearance of IgG opsonized RBC with increased sequestration of RBC in the liver was observed in experimental animals infected with AdFc␥RIIA, when compared with noninfected animals and animals infected with AdNull. Some degree of enhancement of the clearance of opsonized RRBC was also observed after infection with AdNull compared with noninfected animals. This is likely due to activation of resident phagocytic cells by administration of the Ad vector per se, because there was no expression of the human Fc␥RIIA visible in the AdNullinfected animals. Infection with the Ad vectors (AdFc␥RIIA, AdNull) did not affect the clearance of nonopsonized RBC. The increased localization of IgG-coated fluorescent microspheres after Ad Fc␥RIIA transfer in vivo in the liver provide additional evidence for increased uptake of IgG opsonized particles by liver cells of these animals.
Possible clinical significance. One application of this approach may be in in vivo enhancement of host defense in clinical situations in which phagocytosis of IgG-targeted complexes is impaired due to the downregulation of the Fc␥ receptors, eg, in systemic lupus erythematosus, chronic liver disease, and chronic kidney disease. [5] [6] [7] In regard to defects that alter the binding of IgG-coated targets due to genetic polymorphisms (and resulting dysfunction of Fc␥RIIA), an arginine (R131)/histidine change at amino acid position 131 in the second Ig-like domain of the Fc␥RIIA receptor is common. 28, 29 This mutation is clinically significant because Fc␥RIIA on leukocytes of individuals homozygous for R131/R131 (ϳ25% of Caucassians) are unable to efficiently bind IgG2-opsonized bacteria. These individuals have a higher incidence of infections with encapsulated bacteria and increased mortality. 30, 31 The R131/R131 genotype is also a risk factor for development of lupus nephritis in patients with systemic lupus erythematosus probably due to its lower affinity for certain immune complexes. 34 Production of reactive oxygen intermediates by neutrophils in response to antineutrophil cytoplasmic antibodies is also significantly increased in individuals with Wegener's granulomatosis who express the R131/R131 genotype. 35, 36 
